115 related articles for article (PubMed ID: 36000815)
1. Post-recurrence survival analysis of patients with pulmonary recurrence from gynaecologic cancers: a multi-institutional analysis of 122 patients.
Ersak B; Akar S; Demirayak G; Tokalioğlu AA; Aytekin O; Çakir C; Yüksel D; Tokgözoğlu N; Karakaş S; Önder AB; Çelik F; Ayhan S; Ünsal M; Boran N; Kiliç F; Cömert GK; Üreyen I; Toptaş T; Korkmaz V; Özdemir İA; Taşçi T; Türkmen O; Moraloğlu Tekin Ö; Engin-Üstün Y; Turan T
J Obstet Gynaecol; 2022 Oct; 42(7):3277-3284. PubMed ID: 36000815
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary recurrence after radical hysterectomy for uterine cervical carcinoma.
Kilic C; Yuksel D; Cakir C; Karalok A; Boyraz G; Moraloglu Tekin O; Turan T
J Obstet Gynaecol; 2020 Nov; 40(8):1155-1159. PubMed ID: 32027187
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
Kongsawatvorakul C; Charakorn C; Chittithaworn S; Lertkhachonsuk AA
J Obstet Gynaecol; 2022 Aug; 42(6):2331-2335. PubMed ID: 35470751
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
5. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
Kumar S; Srinivasan A; Phillips A; Madhupriya R; Pascoe J; Nevin J; Elattar A; Balega J; Cummins C; Sundar S; Kehoe ST; Singh K
J Obstet Gynaecol; 2020 Aug; 40(6):849-855. PubMed ID: 31933417
[TBL] [Abstract][Full Text] [Related]
6. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
7. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
[TBL] [Abstract][Full Text] [Related]
8. Referral patterns for gynaecologic cancers and precancerous conditions.
Gagliardi A; DePetrillo D; Elit L
J Obstet Gynaecol Can; 2002 Jul; 24(7):553-8. PubMed ID: 12196846
[TBL] [Abstract][Full Text] [Related]
9. Continuous oral cyclophosphamide as salvage or maintenance therapy in ovarian, primary peritoneal, and fallopian tube cancers: A retrospective, single institute study.
Wong CN; Wong CN; Liu FS
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):302-305. PubMed ID: 28600037
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
11. The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control study.
Oz M; Meydanli MM; Altintas MI; Akilli H; Gultekin M; Ozgul N; Salman MC; Taskin S; Yaprak E; Taskiran C; Vatansever D; Giray B; Yetkinel S; Celik H; Onan MA; Ayhan A
J Obstet Gynaecol; 2022 Jul; 42(5):1286-1292. PubMed ID: 34704523
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.
; ; . PubMed ID: 18830625
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]